Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Paclitaxel and Calcium Supplement

Research Papers that Mention the Interaction

The effects of adding paclitaxel were … subset analysis, the hazard ratio of CA … paclitaxel versus CA alone was 0.72 (95% confidence interval, 0.59 to 0.86) for those with estrogen … to 1.07) for patients with estrogen receptor-positive tumors, almost all of whom received adjuvant tamoxifen.
The hazard reductions from adding paclitaxel to CA were 17% for recurrence (adjusted Wald chi(2) P =.0023; unadjusted Wilcoxon P =.0011) and 18% for death (adjusted P =.0064; unadjusted P =.0098).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology  •  2003  |  View Paper
Calcium also acts as a direct biological barrier for paclitaxel uptake during DCB inflation, influencing the homogenous distribution of the drug such that an adequate concentration cannot be predicted.
Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists  •  2016  |  View Paper
Taxol , another antineoplastic drug, specifically inhibited calcium triggered exocytosis.
Pharmaceutical Research  •  2004  |  View Paper
Pretreatment of cells with Taxol and cold storage in the UW solution with 1.5 mM Ca suppressed both bleb formation and LDH release in 48-hr coldstored cells.
Transplantation  •  1999  |  View Paper
Taxol significantly inhibited contraction induced by phenylephrine, angiotensin II, phorbol 12,13-dibutyrate and increasing concentrations of calcium.
Life sciences  •  1995  |  View Paper
Taxol stabilizes microtubules against the depolymerizing effects of cold temperature, drugs and Ca++.
The Journal of pharmacology and experimental therapeutics  •  1991  |  View Paper